M&A Deal Summary

Teva Pharmaceutical Industries Acquires Representaciones e Investigaciones Medicas S.A. de C.V.

On October 1, 2015, Teva Pharmaceutical Industries acquired life science company Representaciones e Investigaciones Medicas S.A. de C.V. for 2.3B USD

Acquisition Highlights
  • This is Teva Pharmaceutical Industries’ 20th transaction in the Life Science sector.
  • This is Teva Pharmaceutical Industries’ 8th largest (disclosed) transaction.
  • This is Teva Pharmaceutical Industries’ 1st transaction in Mexico.

M&A Deal Summary

Date 2015-10-01
Target Representaciones e Investigaciones Medicas S.A. de C.V.
Sector Life Science
Buyer(s) Teva Pharmaceutical Industries
Deal Type Add-on Acquisition
Deal Value 2.3B USD
Advisor(s) Goldman Sachs Investment Banking Division (Financial)

Target

Representaciones e Investigaciones Medicas S.A. de C.V.

Mexico City, Mexico
website
Representaciones e Investigaciones Medicas S.A. de C.V. is a pharmaceutical company. Rimsa designs, develops, manufactures and markets generic drug products.

Search 177,534 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teva Pharmaceutical Industries

Tel Aviv, Israel

website


Category Company
Founded 1901
Sector Life Science
Employees34,713
Revenue 15.9B USD (2021)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.


DEAL STATS #
Overall 22 of 23
Sector (Life Science) 20 of 20
Type (Add-on Acquisition) 19 of 19
Country (Mexico) 1 of 1
Year (2015) 5 of 5
Size (of disclosed) 8 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-25 Gecko Health Innovations

Cambridge, Massachusetts, United States

Gecko Health Innovations, Inc. is a provider of a cloud-based solution designed to simplify chronic respiratory disease management, connecting patients and caregivers through remote monitoring and real-time adherence tools.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-21 Teva Pharmaceutical Industries - Generic Products

Petach Tikva, Israel

Teva Pharmaceutical Industries Ltd. - Generic Products includes solid oral, inhalable, injectable and topical dosage forms and the return to Impax of its rights to its pending abbreviated new drug application ("ANDA") for the generic equivalent to Concerta.

Sell $586M